(PharmaNewsWire.Com, January 21, 2017 ) Blood testing is a laboratory based analysis that is performed in order to determine general state of health, presence of a bacteria or virus and to assess disease progression. It is usually performed by taking a small sample of blood from the patient’s body with the help of a needle or finger prick. Cancer, cardiovascular diseases, acquired immunodeficiency syndrome (AIDS)/HIV, anemia and diabetes are some major diseases for which blood testing is recommended so as to confirm the diseased condition. Blood testing is also performed in order to assess how well body vital organs such as liver, kidney and thyroid are functioning. Blood testing is very common and is often recommended by physicians for analyzing the normal body functioning. Some major blood tests that are widely used for diagnosing various diseases include full blood count (FBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) test, coagulation test, electrolyte test, thyroid function test, enzyme-linked immunosorbent assay (ELISA) test, karotyping, blood cholesterol test and liver function test.
The market for blood testing continued to grow under the influence of aging population, rise in incidences of various diseases such as hepatitis, human immunodeficiency virus (HIV) infection, cancer, thyroids, genetic disorders and bacterial and viral allergic disorders, and expanding application of blood testing in other diagnostic areas. The market for blood testing is also growing owing to burgeoning demand for point of care testing (POCT). POCT majorly includes blood glucose testing, electrolyte testing and coagulation testing. POCT offers rapid diagnosis by performing test at or near patient’s location and does not cause patients to wait for a longer time in order to get test result. Technical advances leading to the development of innovative testing tools and equipment such as automated blood collection equipment is also playing a key role in driving the market growth for blood testing.
Some of the major players in this market are Abbott Laboratories, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Baxter International, Gen-Probe, Inc., Novartis Diagnostics, Roche Diagnostics, Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Inc., Cepheid Corporation, Meridian Bioscience, Inc., Trinity Biotech and Alere, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
